Identifikujte potencijalne rizike, neusklađenosti i upozorenja u svim tenderskim dokumentima. Dobijte detaljan izveštaj o rizicima sa nivoima ozbiljnosti i preporukama za ublažavanje.
Prijavite seDobijte AI strategiju za pobedu prilagođenu ovom tenderu. Uključuje ocenu verovatnoće pobede, ključne prilike i izazove, preporučene oblasti fokusa za ponudu, uvide u konkurentsko pozicioniranje i konkretne preporuke za maksimiziranje vaših šansi.
Prijavite seNadogradite da biste videli koje kompanije će se verovatno nadmetati na ovom tenderu, na osnovu istorijskih podataka o javnim nabavkama.
Prijavite se17 zahteva u 5 kategorija
Registrujte se da biste videli potpune zahteve i analizu
7 dokumenata dostupno sa AI sažecima
Kuressaare Hospital Foundation is buying a daratumumab-based cancer/immunomodulatory drug, so only suppliers that can (1) confirm full compliance with the tender terms, (2) submit the completed “HD Annex I Drug Description” form, and (3) price the product in the exact Excel cost sheet, should bid—conditional or non-conforming offers are rejected.
Rahvusvahelises formaadis laiendatud ESPD (Hankepass) vorm, mida hankelepingu pakkujad peavad esitama oma majandusliku ja kvalifikatsioonilise seisundi tõendamiseks.
This is a 100% price-only (mandatory) procurement by Kuressaare Haigla for a 2-year supply of daratumumab-based cancer/immunomodulatory drugs, so any supplier that can deliver the exact active ingredient at the lowest tax-excluded unit price in EUR should bid.
Kuressaare Hospital is running an open, single-drug procurement (CPV 33600000-6) solely for daratumumab-containing cancer/immunomodulatory medicines—bidders must simply register their company details and confirm no exclusion grounds in the ESPD, making this a straightforward, low-barrier tender for any authorised daratumumab supplier.
Kuressaare Hospital is tendering a 2-year, non-binding supply of the mandatory monoclonal-antibody cancer drug Daratumumab 1800 mg/15 ml injection (72 vials) and will award solely on the lowest unit price ex-VAT, so only pharmaceutical wholesalers holding the exact product and able to quote the cheapest via-level price should bid.
Kuressaare Hospital seeks a 24-month supply of daratumumab-containing cancer/immunomodulatory drugs, delivered within 3 working days of monthly orders, with bidders required to prove clear title, provide quality certificates and accept that the stated maximum price can only fall—mandatory compliance with all delivery, documentation and liability terms in the draft contract.
Kuressaare Hospital wants to buy a single daratumumab-based cancer drug for ~2 years; bidders must hold a valid Estonian wholesale licence (mandatory) and the product must have a current marketing authorisation listed in Estonia’s drug register (mandatory).
Registrujte se da biste videli sažetke i analizu dokumenata
Sveobuhvatna analiza kvaliteta ovog tendera koja ocenjuje pravnu usklađenost, jasnoću, kompletnost, pravičnost, praktičnost, konzistentnost podataka i održivost na skali od 0-100 sa detaljnim pregledom i preporukama.
Prijavite seNaši stručnjaci za javne nabavke pripremaju sve. Dokazano efikasno — Vi pregledate, odobrite i predate.
Poštovani! Ja sam vaš AI asistent za ovaj tender. Mogu vam pomoći da razumete zahteve, rokove, kriterijume za ispunjenost uslova i pružiti strateške uvide.
Nije potrebna kreditna kartica